Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Submitted by
admin
on April 4, 2017 - 11:01pm
Source:
Marketwatch
News Tags:
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Headline:
Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Do Not Allow Advertisers to Use My Personal information
